Itaru Sanoyama

Sagamihara, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Epigenomic profiling of neuroendocrine lung cancers identifies a classical-neuroendocrine ASCL1/NKX2-1 subtype and a SOX11-associated differentiation axis linked to reduced immunogenicity.

Epigenomic profiling of neuroendocrine lung cancers identifies a classical-neuroendocrine ASCL1/NKX2-1 subtype and a SOX11-associated differentiation axis linked to reduced immunogenicity.

Journal: Lung cancer (Amsterdam, Netherlands)
Published: April 06, 2026

CD109 Expression in Tumor and Stromal Cells Serves as a Prognostic Biomarker for Tumor Progression and Outcome in Gallbladder Adenocarcinoma.

CD109 Expression in Tumor and Stromal Cells Serves as a Prognostic Biomarker for Tumor Progression and Outcome in Gallbladder Adenocarcinoma.

Journal: Pathology international
Published: October 25, 2025

REV7 Expression Is Associated with Tumor Cell Growth and Cisplatin Resistance in Gallbladder Adenocarcinoma.

REV7 Expression Is Associated with Tumor Cell Growth and Cisplatin Resistance in Gallbladder Adenocarcinoma.

Journal: Pathobiology : journal of immunopathology, molecular and cellular biology
Published: June 22, 2025

Two Giant Cystic Uterine Adenomyomas in a Premenopausal Woman: The Largest Case to Date With Immunohistochemical Findings.

Two Giant Cystic Uterine Adenomyomas in a Premenopausal Woman: The Largest Case to Date With Immunohistochemical Findings.

Journal: Case reports in obstetrics and gynecology
Published: November 08, 2024

Elevated expression of REV7 correlates with poor prognosis in lung adenocarcinoma and its inactivation in carcinoma cells enhances chemosensitivity.

Elevated expression of REV7 correlates with poor prognosis in lung adenocarcinoma and its inactivation in carcinoma cells enhances chemosensitivity.

Journal: Pathology, research and practice
Published: October 25, 2024

High levels of REV7 expression are associated with poor prognosis and chemoresistance in gastric adenocarcinoma.

High levels of REV7 expression are associated with poor prognosis and chemoresistance in gastric adenocarcinoma.

Journal: Pathology international
Published: September 07, 2024

Prenatal features of congenital peribronchial myofibroblastic tumor.

Prenatal features of congenital peribronchial myofibroblastic tumor.

Journal: Radiology case reports
Published: October 30, 2023

REV7 is involved in outcomes of platinum-based chemotherapy in pancreatic cancer by controlling the DNA damage response.

REV7 is involved in outcomes of platinum-based chemotherapy in pancreatic cancer by controlling the DNA damage response.

Journal: Cancer science
Published: September 05, 2023

Splenectomy for Torsion of a Wandering Spleen in a Patient with Myeloproliferative Disease.

Splenectomy for Torsion of a Wandering Spleen in a Patient with Myeloproliferative Disease.

Journal: Internal medicine (Tokyo, Japan)
Published: December 13, 2021

A case of immune checkpoint inhibitor-associated myocarditis after initiation of atezolizumab plus bevacizumab therapy for advanced hepatocellular carcinoma.

A case of immune checkpoint inhibitor-associated myocarditis after initiation of atezolizumab plus bevacizumab therapy for advanced hepatocellular carcinoma.

Journal: Clinical journal of gastroenterology
Published: March 10, 2021

Increased expression of REV7 in small cell lung carcinomas and its association with tumor cell survival and proliferation.

Increased expression of REV7 in small cell lung carcinomas and its association with tumor cell survival and proliferation.

Journal: Pathology international
Published: September 14, 2020

Inactivation of REV7 enhances chemosensitivity and overcomes acquired chemoresistance in testicular germ cell tumors.

Inactivation of REV7 enhances chemosensitivity and overcomes acquired chemoresistance in testicular germ cell tumors.

Journal: Cancer letters
Published: March 19, 2020
Showing 1-12 of 13

Last Updated: 09/26/2026